| Bioactivity | Ruzinurad is a highly selective URATl inhibitor (WO2020088641, compound I). Ruzinurad can be used in the study of hyperuricemia[1]. | ||||||||||||
| Target | URAT1 | ||||||||||||
| Invitro | Ruzinurad is a highly selective URATl inhibitor[1]. | ||||||||||||
| Name | Ruzinurad | ||||||||||||
| CAS | 1638327-48-6 | ||||||||||||
| Formula | C14H12BrNO2S | ||||||||||||
| Molar Mass | 338.22 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO2020088641 |
Ruzinurad
CAS: 1638327-48-6 F: C14H12BrNO2S W: 338.22
Ruzinurad is a highly selective URATl inhibitor (WO2020088641, compound I). Ruzinurad can be used in the study of hyperu
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.